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Objective: To examine the effect of using a mitt during short-
ened constraint-induced movement therapy for patients in 
the subacute phase after stroke. 
Subjects: Twenty-four patients with stroke (mean age 57.6 
(standard deviation 8.5) years; average 7 weeks post-stroke) 
with mild to moderate impaired hand function.
Methods: The patients were randomized to mitt use or no 
mitt use on the less affected hand for 90% of waking hours 
for 12 days. All patients received 3 h of arm and hand train-
ing per day for 2 weeks. Assessments were made by blinded 
observers using the modified Motor Assessment Scale, the 
Sollerman hand function test, the 2-Point Discrimination 
test and Motor Activity Log test. 
Results: Patients in both groups showed significant im-
provements in arm and hand motor performance and on 
self- reported motor ability after 2 weeks of therapy and at 
3 months follow-up. However, no statistically significant dif-
ferences between the groups were found in any measures at 
any point in time.
Conclusion: In this study, no effect of using a restraint in 
patients with subacute stroke was found. Thus, this compo-
nent in the constraint-induced therapy concept seems to be 
of minor importance for the outcome.
Key words: constraint-induced therapy, rehabilitation, restraint, 
stroke. 
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INTRODUCTION
Constraint-induced movement therapy (CIT) is a family of 
treatment techniques that aims to increase the use of the more 
affected hand in daily activities and to improve motor function 
following a central nervous system lesion. The therapy is based 
on primate research in which somatic sensation was surgically 
abolished by dorsal rhizotomy of a single forelimb. Deprived 
of sensory feedback, the monkeys did not use the forelimb 
unless they were forced to do so, and consequently it has been 
assumed that they developed a learned non-use phenomenon 
(1–3). The mechanism of learned non-use is thought to apply 
also to humans who suffer from hemiparesis after stroke. 
In traditional CIT, the patients perform exercises for 6 h per 
day and simultaneously wear a mitt on the less affected arm for 
90% of waking hours during 2 weeks to overcome the learned 
non-use phenomenon (4–7). There is concern about the resource 
issues necessary to carry out CIT according to the original 
model of Taub (8). Therefore, to make the CIT clinically adapt-
able, various modifications of the original concept have been 
attempted; for example, shortened CIT (sCIT) (9), forced use 
therapy (FUT) (10, 11), modified CIT (12), automated delivery 
of CIT (13), distributed CIT (14) and group CIT (15). 
Few studies concerning CIT have been published for stroke 
patients in the subacute phase (usually defined as 0.5–3 months 
post-stroke (6)). Promising trends in improved function have 
been reported both after traditional CIT (7, 16) and after modi-
fied CIT (17–19) (consisting of 3 h of training per week for 
10 weeks with the intact arm in restraint for 5 days/week during 
5 h/day) in the subacute phase after stroke. 
It is, however, not clear which aspects of the CIT treatment 
regime – the amount and mode of training per day or the 
restraint – are necessary for a beneficial effect. Only a few 
researchers have investigated the effect of wearing a mitt. 
Promising results have been reported after FUT in patients 
with chronic stroke and traumatic brain injury (TBI) (20) and 
after mitt use in patients 1–12 months post-stroke (21), but 
there were no control groups in these 2 studies. In another 
randomized study (10) only small improvements in hand func-
tion were found in favour of the FUT group (being restrained) 
compared with the control group. In our previous study (15) 
no additional effect on arm and hand function was seen after 
extended mitt use. 
To gain a better understanding of which component in the 
CIT concept is important for the outcome, the aim of this study 
was to determine whether wearing a mitt enhances a possible 
improvement in arm- and hand-function in patients with su-
bacute stroke. In this early phase after stroke onset we used a 
3-h training protocol for 2 weeks, corresponding to sCIT (9). 
The patients were randomized to mitt use or no mitt use and 
were assessed by blinded observers. 
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PATIENTS AND METHODS
Patients
Patients were recruited consecutively between September 2001 and 
November 2005 to the Department of Rehabilitation at Lund University 
Hospital, Sweden, where the stroke rehabilitation team works mainly 
with patients below retirement age. After providing informed consent, 
the patients were offered participation in the study as soon as they met 
the following criteria: (i) a history of a single stroke onset; (ii) between 
1 and 3 months post-stroke; (iii) ability to dorsiflex (extend) the wrist 
on the more affected hand at least 10º and to extend 2 fingers at least 
10º and to abduct the thumb at least 10º (i.e. had mild to moderate 
impairments of hand function); (iv) had a grasping score ≤ 65/80 points 
on the Sollerman Hand Function Test (22, 23); (v) only minimal bal-
ance problems, i.e. were able to walk 20 m within 40 sec; (vi) no gross 
language deficits (≥ 4 out of 6 parts on the Token test) (24); (vii) no 
severe cognitive impairments (Mini-Mental State Examination > 24/30 
(25)). The exclusion criteria were: deformity of the more affected arm 
due to previous injury, drug abuse, epilepsy, mental disorder (ICD-10), 
and botulinum toxin injections for spasticity treatment.
Patients included
Twenty-four patients agreed to participate in the study (18 men and 
6 women; mean age 57.6 (standard deviation (SD)) 8.5 years; mean 
time post-stroke 7.0 (SD) 2.7 weeks). Sixteen patients had right-sided 
hemiparesis and the dominant hand was affected in 14 patients. The 
patients’ characteristics for the mitt group and the non-mitt group can 
be seen in Table I. No differences in assessment measures were seen 
between the groups at study entry. 
Protocol
At study entry the patients were randomized to sCIT either with (mitt 
group) or without a mitt (non-mitt group). Randomization was per-
formed from a computer-generated list of consecutive random numbers. 
All patients received approximately 3 h of training per weekday of 
the more affected arm and hand for 2 weeks. Those randomized to 
the mitt group were requested and encouraged to wear a mitt on the 
less affected hand for 90% of waking hours over the same period plus 
the intervening weekend. The time of wearing the mitt per day was 
written in a log book and checked several days per week by the staff. 
The mitts (Fig. 1) were manufactured in the occupational therapy 
section of our department (no commercial enterprise involved) and 
used to prevent the patients from grasping objects with their less 
affected hand in activities. In addition to the arm and hand interven-
tions (below), all patients were given gait and balance training (15–30 
min/day) as needed.
Intervention
The arm and hand exercises consisted of: 
•	 task	practise, such as moving objects from one shelf to another, 
pouring water into mugs from a jar, putting objects through a slot, 
typing; 
•	 fine	motor	practise,	such as fastening nuts on bolts, putting pegs in 
a board, buttoning and unbuttoning, writing; 
•	 muscle	strength	training	through pulling weights; 
•	 muscle	stretching;	
•	 swimming-pool	training	for active range of motion; 
•	 general	activity	training, such as laying the table, cleaning a window, 
making coffee or lunch, washing the dishes, office work, handicrafts, 
playing games and indoor sports.
The patients performed the exercises supervised by staff (physio-
therapists, occupational therapists and staff nurses) during most of the 
daily 3-hour training periods. There was no turn-over of staff during the 
study period and the trainers had many years of experience of stroke 
rehabilitation. The training programme was individualized for each 
patient in accordance to the patient’s sensorimotor capacity and goals. 
The tasks were approached in steps of progressively increasing dif-
ficulty and included verbal feedback on the quality of the movements, 
similar to the “shaping” described by Taub et al. (26). The patients in 
both groups were encouraged to use the more affected hand as much 
as possible in different activities. The patients in the mitt group used 
log books to document the time of use of the restraint during the 2 
weeks. The mitts were taken away at discharge. 
Outcome measures
All patients were assessed by independent and blinded assessors (li-
censed occupational therapist and physiotherapist) before and after 2 
weeks of therapy as well as after 3 months. The instruments used for as-
sessment were: (i) the modified Motor Assessment Scale (MAS) (27–29), 
tested for validity and reliability (28, 29) (items used for upper extremity 
only; both arms were tested) consisting of 15 tasks from gross arm to 
fine finger movements in a 0–5 point scale; (ii) the Sollerman Hand 
Function Test (22), tested for validity (22) and found to be reliable for 
patients with stroke (23), consisting of 20 sub-tests reflecting daily hand 
activities (type of grasp, quality of movement and speed of performance 
assessed in a 0–4 point scale); (iii) the 2-Point Discrimination Test (2-
PD) (30) that measures the tactile somatosensation in a 0–10 point scale 
with 2 mm interval between the points (if the patient could not estimate 
the 10 mm distance between the points of the affected fingers, the total 
score was set to 50); and (iv) the Motor Activity Log (MAL), tested for 
validity and reliability (31–33), a 30-item questionnaire adapted version 
by Taub et al. (34), which asks the subject how often (amount of use 
(AOU)) and how well (quality of movement (QOM)) the affected hand 
is used for the daily activities in a 0–5 point scale. 
Statistical analyses
All data were tested for normality using the Graph Pad Instat® program. 
The data for the MAS test was found to be skewed at the 3 months 
follow-up. To detect significant mean differences within groups pre- 
and post-treatment and at 3 months follow-up repeated measures 
Table I. Patients’ characteristics according to randomization schedule 
before therapy for the mitt group and the non-mitt group, respectively
Mitt group 
(n = 12) 
Non-mitt group 
(n = 12)
Age, years, mean (SD) 58.5 (6.2) 56.7 (10.5)
Weeks post-stroke, mean (SD) 6.7 (2.3) 7.3 (3.1)
Gender, men/women, n 10/2 8/4
Hemipares, right/left, n 7/5 9/3
Handedness, right/left, n 10/2 11/1
SD: standard deviation.
Fig. 1. The mitt used in this study.
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analysis with analysis of variance (ANOVA) and Tukey’s post-hoc 
test was used for the 2-PD test (parametric data), whereas the Fried-
man test with Dunn’s post-hoc test was used for the Sollerman hand 
function test as well as for the MAS and the MAL tests, respectively 
(non-parametric data). In clinical practice as well as in research the 
total sum scores of the Sollerman hand function test and the MAS test 
are often used. They represent a clinically relevant overall measure 
of hand and arm function, albeit non-linear, and were analysed here 
with non-parametric tests. For one patient in the mitt group, data was 
missing at the 3-month follow-up (due to a new stroke onset), and the 
post-treatment assessment values were used in the ANOVA analysis 
at 3-month follow-up (according to the “last value carried forward” 
principle (35)). 
To detect significant mean differences between groups (mitt/non-mitt) 
pre- and post-treatment as well as post-treatment and the 3 months fol-
low-up, independent sample t-test was used for the 2-PD test, whereas 
the Mann-Whitney U-test was used for the Sollerman hand function test 
and for MAS and MAL, respectively. The data were analysed using the 
Graph Pad Instat® program and the Statistical Package for the Social 
Sciences (SPSS) version 12.0 Software for Windows (SPSS, Chicago, 
IL, USA). A p-value < 0.05 was considered significant.
The research protocol was approved by the medical ethics commit-
tee of Lund University. 
RESULTS
Effects of training 
Large improvements in arm and hand function were found in 
both the mitt group and the non-mitt group on the Sollerman 
hand function test (p < 0.0001)/(p < 0.0001; Friedman), on the 
MAS test (p < 0.0003)/(p < 0.004; Friedman) and on the MAL 
test (p < 0.0002)/(p < 0.001; Friedman), respectively. 
The median score difference for the mitt group (n = 12) on the 
Sollerman hand function test (Fig. 2A) was 16.5 points (p < 0.05) 
pre-to post-treatment, 5.0 points (p > 0.05) post-treatment to 3 
months follow-up and 21.5 points (p < 0.001) pre-treatment to 
the 3 months follow-up (Dunn’s post-hoc test). The median score 
difference on the MAS test (Fig. 2B) was 2.0 points (p > 0.05) 
pre- to post-treatment, 2.0 points (p > 0.05) post-treatment to the 
3 months follow-up and 4.0 points (p < 0.01) pre-treatment to the 
3 months follow-up. The median score difference on the MAL 
test on AOU/QOM (Fig. 3A and B) was 0.75 points/0.85 points 
(p > 0.05) pre- to post-treatment, 0.4 points/0.3 points (p > 0.05) 
post-treatment to the 3 months follow-up and 1.15 points/1.15 
points (p < 0.001) pre-treatment to the 3 months follow-up. No 
significant changes in sensory discrimination (2-PD test; Fig. 4) 
were found (p = 0.976) within the mitt use group. 
Large improvements in arm and hand function were also found 
in the non-mitt group (n = 12). The median score difference on 
the Sollerman Hand Function Test (Fig. 2A) was 11.5 points 
(p < 0.05) pre- to post-treatment, 3.0 points (p > 0.05) post-
treatment to the 3 months follow-up and 14.5 points (p < 0.001) 
pre-treatment to the 3 months follow-up. The median score 
difference on the MAS test (Fig. 2B) was 5.0 points (p < 0.05) 
pre- to post-treatment, 1.0 points (p > 0.05) post-treatment to 
the 3 months follow-up and 6.0 points (p < 0.01) pre-treatment 
to 3 months follow-up. The median score difference on the 
MAL test AOU/QOM (Fig. 3A and B) was 0.5 points/0.7 points 
(p > 0.05/p < 0.01) pre- to post-treatment, 0.65 points/0.4 points 
(p > 0.05) post-treatment to the 3 months follow-up and 1.15 
points/1.1 points (p < 0.01) pre-treatment to the 3 months follow-
up. No significant changes in sensory discrimination (2-PD test; 
Fig. 4) were found (p = 0.7) within the non-mitt use group.
Thus, both groups improved their arm and hand motor per-
formance significantly, but no differences (p > 0.05) were found 
between the groups in any measures at any point in time.
Mitt compliance
According to the logs, 10/12 patients reported successful accom-
plishment in using restraints for approximately 90% of waking 
hours. The remaining 2 patients had some difficulties in compli-
ance and used the mitt for approximately 80% of waking hours. 
DISCUSSION
The present results indicate that sCIT for 2 weeks in a selected 
group of patients after subacute stroke with a moderately 
impaired hand function is beneficial, but wearing a mitt on 
Fig. 2. Box-plots with medians and minimum/maximum values for the 
mitt group (dark-grey box-plots) and the non-mitt group (light-grey 
box-plots) on (A) the Sollerman hand function test (0–80 points) and (B) 
the Motor Assessment Scale (0–30 points), before and after 2 weeks of 
therapy and at 3 months follow-up. Outliers are denoted with (○).*p < 0.05, 
**p < 0.01, ***p < 0.001.
Fig. 3. Box-plots with medians and minimum/maximum values for the 
mitt group (dark-grey box-plots) and for the non-mitt group (light-grey 
box-plots) on the Motor Activity Log (MAL): (A) amount of use (AOU; 
0–5 points) and (B) quality of movements (QOM; 0–5 points), before and 
after 2 weeks of therapy and at 3 months follow-up. Outliers are denoted 
with (○).  **p < 0.01, ***p < 0.001. 
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the less affected hand does not seem to add further value to 
improve upper extremity function. 
The mitt did not enhance improvements in arm function 
after 2 weeks of training in this study, despite satisfactory mitt 
compliance in the mitt group. This result disagrees with other 
published studies that have evaluated the effect of forced use 
therapy (i.e. mitt use) (20, 21). Reasons for the differences 
in outcomes might be that the patients in our study were in 
the early post-stroke phase, but also that control groups in 
the 2 studies by Wolf et al. (20) and Burns et al. (21) were 
missing. In another randomized control study (10) only small 
gains in hand function were reported in favour of the FUT 
group compared with the bimanual group (without using 
a restraint). It may be argued that our results differ from 
others because no behavioural contract was administered, 
something other workers have tried to counter by introduc-
ing a “transfer package” (36), and that our patients did not 
comply with our recommendations to wear a mitt during the 
whole period. However, our mitt log data speak against such 
an explanation.
We have previously examined the effect of extended mitt 
use in a group of patients with chronic stroke (15). Significant 
improvements in arm function were observed after 2 weeks of 
group CIT, but no further improvements could be demonstrat-
ed after an extended mitt use for another 3 months. Taken to-
gether, these findings indicate that mitt use might be of minor 
importance for improving upper extremity function and may 
therefore question the original “learned non-use hypothesis”. 
In humans, but not in monkeys, there is also the possibility 
of a “cognitive mitt effect”, i.e. patients who have agreed to 
participate in CIT are often highly motivated and aware of the 
importance of using their more affected hand in daily activities 
to be able to achieve motor improvements. This awareness 
and determination might in fact limit the need to use a mitt 
on the less affected hand. Alternatively, the present group of 
patients with subacute stroke may not yet have developed a 
full “learned non-use” phenomenon and hence the effect of 
mitt use would be more difficult to demonstrate.
In our study, improvements in arm and hand motor function 
were observed in both groups after 2 weeks of sCIT. The lack 
of change in the 2-point discrimination test is not unexpected 
since it is a measure of somatosensory function rather than of 
motor plasticity. 
Improvements in arm and hand function after intensive train-
ing (6 h/day for 2 weeks) without using restraint have been 
reported in patients with chronic stroke (4, 5, 37, 38). The 
gains after therapy were comparable to those who had been 
restrained with a sling and had received shaping exercises or 
task practise (4, 37). However, at 2 years follow-up the remain-
ing effects were somewhat higher for the group that had been 
restrained (37). In a systematic review Van der Lee et al. (39) 
concluded that only a more intensive arm and hand exercise 
therapy appears to be beneficial. 
The findings of motor improvements for the non-mitt group 
contrast with the results of other published studies concerning 
modified CIT (17–19) and traditional CIT (7) in the subacute 
phase after stroke. The training for the non-mitt group in our 
study was more focussed on hand training than described in 
the other studies mentioned above (17–19). Since it has been 
found previously that the main part of spontaneous recovery 
occurs within the first 3 months after the stroke (40), it might be 
argued that the improvements observed here in patients mainly 
below retiring age and with a mean of 7 weeks post-stroke are 
partly due to spontaneous recovery. However, the results from 
the previously quoted studies (7, 17–19) speak against such an 
interpretation. For ethical reasons, it is not possible to leave 
any patients without “treatment as usual” (i.e. a control group 
without training) in modern healthcare and therefore, one has 
to resort to therapy comparison designs. 
Taub and co-workers (4, 5, 26) have emphasized the impor-
tance of shaping exercises in CIT, but the results from different 
studies are contradictory (11, 41). When the present study was 
designed, detailed information on the execution of shaping 
exercises was not generally available from the literature. The 
training given to our patients had a gradually increasing level 
of difficulty and feedback was mainly given concerning the 
quality of movements.
A limitation in our pilot study is the relatively small sample 
size and the lack of a pre-study power analysis. However, a 
post-hoc power analysis utilizing the standard deviations ob-
served, indicate that for within-group comparisons, based on 
12 pairs, the sensitivity is sufficient to detect a difference of 
12–13 points with 80% power. On the other hand, the between-
group comparison showed minimal insignificant differences 
here and would take 300 patients per group to have sufficient 
sensitivity at 80% power to detect systematically differences 
at such small magnitudes. Had the differences between the 
mitt and the non-mitt groups been of similar magnitudes as 
those within groups, there would have been no difficulty in 
detecting them with this design. 
Even so, this study is larger than most of the hitherto pub-
lished studies concerning shortened CIT for patients with 
subacute stroke (16–19, 42). We aimed to include 30 patients 
in the study, but due to problems of recruiting patients (to meet 
the inclusion criteria) we decided to close the study after 4 
years with a total of 24 patients. During these years most of 
the staff was the same, which optimized the standardization 
conditions for the training and assessment procedures. Even 
Fig. 4. Mean and 95% confidence intervals (CI) on the 2-Point 
Discrimination test (2-PD; 0–50 mm) before and after therapy and at 3 
months follow-up for the mitt group and for the non-mitt group. 
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though the trainers were aware of which patients wore a mitt, 
the present results do not indicate an expectancy effect from 
either the trainers or the patients, possibly other than that on 
the MAL. Nevertheless, the MAL has the limitations of being 
a self-assessment instrument.
In conclusion, 3 h of sCIT during 2 weeks in the subacute 
phase after stroke seems to be beneficial, but wearing a restraint 
does not seem to be necessary. Thus, the importance of this 
component in the CIT concept can be questioned. Future larger 
and controlled studies of specific practises vs restraint use are 
needed to demonstrate which component is most important for 
a beneficial outcome. 
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